CHILDRENS ACETAMINOPHEN and FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT

3 reports of this reaction

5.8% of all CHILDRENS ACETAMINOPHEN reports

#2 most reported adverse reaction

Overview

FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT is the #2 most commonly reported adverse reaction for CHILDRENS ACETAMINOPHEN, manufactured by AARNA USA INC.. There are 3 FDA adverse event reports linking CHILDRENS ACETAMINOPHEN to FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT. This represents approximately 5.8% of all 52 adverse event reports for this drug.

Patients taking CHILDRENS ACETAMINOPHEN who experience failure of child resistant mechanism for pharmaceutical product should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT3 of 52 reports

FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT is moderately reported among CHILDRENS ACETAMINOPHEN users, representing a notable but not dominant share of adverse events.

Other Side Effects of CHILDRENS ACETAMINOPHEN

In addition to failure of child resistant mechanism for pharmaceutical product, the following adverse reactions have been reported for CHILDRENS ACETAMINOPHEN:

Other Drugs Associated with FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT

The following drugs have also been linked to failure of child resistant mechanism for pharmaceutical product in FDA adverse event reports:

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE

Frequently Asked Questions

Does CHILDRENS ACETAMINOPHEN cause FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT?

FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT has been reported as an adverse event in 3 FDA reports for CHILDRENS ACETAMINOPHEN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT with CHILDRENS ACETAMINOPHEN?

FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT accounts for approximately 5.8% of all adverse event reports for CHILDRENS ACETAMINOPHEN, making it one of the most commonly reported side effect.

What should I do if I experience FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT while taking CHILDRENS ACETAMINOPHEN?

If you experience failure of child resistant mechanism for pharmaceutical product while taking CHILDRENS ACETAMINOPHEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

CHILDRENS ACETAMINOPHEN Full ProfileAll Drugs Causing FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCTAARNA USA INC. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.